Inhibiting aldosterone synthase reduces blood pressure
- PMID: 36376435
- DOI: 10.1038/s41569-022-00810-w
Inhibiting aldosterone synthase reduces blood pressure
Comment on
-
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.N Engl J Med. 2023 Feb 2;388(5):395-405. doi: 10.1056/NEJMoa2213169. Epub 2022 Nov 7. N Engl J Med. 2023. PMID: 36342143 Clinical Trial.
References
Original article
-
- Freeman, M. W. et al. Phase 2 trial of baxdrostat for treatment-resistant hypertension. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2213169 (2022) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical